MENU
BCAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioAtla (BCAB) Ownership - Who owns BioAtla?
BioAtla Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.56M
P/E Ratio
N/A
Total Cash
56.52M
Projected Growth
N/A
Total Debt
1.25M
Revenue
11M
Risk (Beta)
0.86
Dividend Yield
N/A
Total Cash/Share
0.97
Total Debt/Equity
N/A
Revenue/Share
0.23 USD as % of share price
Fundamentals
BCAB
Capitalization
15.6M
P/E Ratio
N/A
Risk (Beta)
0.86
Dividend Yield
N/A
Total Cash
56.5M
Total Cash/Share
0.97
Total Debt
1.25M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.23%
Revenue
11M
ROE
N/A
Book Value
23M
P/B Ratio
1.09
Cash Flow
N/A
Earnings
-1.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.11
Current Revenue Per Employee
169230.77
Dividends Per Share - Security
N/A
EBITDA
-85.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-76.61
Shares Held By Institutions
17M
Shares Outstanding - Current
58.4M
Total Liabilities
62.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-54.888
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com